Reducing C-section births: MindChild Medical gets FDA win for fetal heart monitor

September 26, 2012 by MassDevice staff

Massachusetts-based medical device company MindChild looks to commercialize a sophisticated fetal heart monitor and reduce the number Caesarean sections for pregnant women.


MindChild Medical received 510(k) clearance from the U.S. FDA for a new fetal heart monitor the company says can detect tiny fluctuations in fetal heartbeats and potentially reduce the number of Caesarean sections pregnant women undergo.

Company officials said the regulatory win clears the way for the company to commercialize its Meridian non-invasive fetal heart monitor.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.